Met Life Investment Management, LLC Maxcyte, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 60,983 shares of MXCT stock, worth $258,567. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,983
Previous 60,983
-0.0%
Holding current value
$258,567
Previous $239,000
0.84%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MXCT
# of Institutions
124Shares Held
65.6MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$34.7 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$34.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$24.5 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$21.4 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$20.4 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $431M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...